|Bid||192.00 x 100|
|Ask||197.27 x 600|
|Day's Range||192.65 - 194.40|
|52 Week Range||161.29 - 206.63|
|PE Ratio (TTM)||56.18|
|Earnings Date||Nov 1, 2017 - Nov 6, 2017|
|Dividend & Yield||2.92 (1.51%)|
|1y Target Est||218.45|
BD (BDX) is a leading player in providing solutions for women's health and sexually transmitted infections. Its latest development is likely to lend the company a competitive edge in the niche space.
Becton, Dickinson and Company's (BDX) latest micro pen needle will enhance the scope of its Diabetic Care unit.
Becton Dickinson and Co NYSE:BDX